|
Perez-Wert P, Custodio A, Jimenez-Fonseca P, Carmona-Bayonas A, Lecumberri A, Cacho Lavin D, Losantos Garcia I, Fernandez Montes A, Cano JM, Limon ML, Hernandez San Gil R, Diez M, Vidal Tocino R, Macias Declara I, Visa L, Pimentel Caceres P, Gil Raga M, Martinez Moreno E, Sauri T, Martin Richard M, Granja M, Cerda P, Gomez Gonzalez L, Merida-Garcia A, Ruiz Martin M, Gallego J; AGAMENON-SEOM study group. Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry. Gastric Cancer. 2024 Jan;27(1):131-145. doi: 10.1007/s10120-023-01443-9. Epub 2023 Nov 15. PubMed PMID: 37964032.
AÑO: 2024; IF: 6.0
|
37964032
|
Paredero-Perez I, Jimenez-Fonseca P, Cano JM, Arrazubi V, Carmona-Bayonas A, Covela-Rua M, Fernandez-Montes A, Martin-Richard M, Girones-Sarrio R. State of the scientific evidence and recommendations for the management of older patients with gastric cancer. J Geriatr Oncol. 2024 Apr;15(3):101657. doi: 10.1016/j.jgo.2023.101657. Epub 2023 Nov 11. PubMed PMID: 37957106.
AÑO: 2024; IF: 3.0
|
|
Contreras-Toledo D, Jimenez-Fonseca P, Lopez CL, Montes AF, Lopez Munoz AM, Vazquez Rivera F, Alonso V, Alcaide J, Salva F, Covela Rua M, Guillot M, Martin Carnicero A, Jimeno Mate R, Cameselle Garcia S, Asensio Martinez E, Gonzalez Astorga B, Fernandez-Diaz AB, Gonzalez Villaroel P, Virgili Manrique AC, Melian Sosa M, Alonso B, Cousillas Castineiras A, Castanon Lopez C, Aparicio J, Carmona-Bayonas A. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist? Br J Cancer. 2024 Mar;130(5):777-787. doi: 10.1038/s41416-023-02563-w. Epub 2024 Jan 8. PubMed PMID: 38191609; PubMed Central PMCID: PMC10912758.
AÑO: 2024; IF: 6.4
|
|
Arias-Martinez A, Martinez de Castro E, Gallego J, Arrazubi V, Custodio A, Fernandez Montes A, Diez M, Hernandez R, Limon ML, Cano JM, Vidal-Tocino R, Macias I, Visa L, Martin Richard M, Sauri T, Hierro C, Gil M, Cerda P, Martinez Moreno E, Martinez Lago N, Merida-Garcia AJ, Gomez Gonzalez L, Garcia Navalon FJ, Ruiz Martin M, Marin G, Lopez-Lopez F, Ruperez Blanco AB, Fernandez AF, Jimenez-Fonseca P, Carmona-Bayonas A, Alvarez-Mancenido F. Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry. Clin Transl Oncol. 2024 Jul;26(7):1674-1686. doi: 10.1007/s12094-024-03388-6. Epub 2024 Feb 15. PubMed PMID: 38361134; PubMed Central PMCID: PMC11178610.
AÑO: 2024; IF: 2.8
|
|
Mihic-Gongora L, Jimenez-Fonseca P, Coca-Membribes S, Cruz-Castellanos P, Galan-Moral R, Asensio-Martinez E, Palacin-Lois M, Carmona-Bayonas A, Carames-Sanchez C, Calderon C. Physical Activity in Patients with Advanced Cancer: Sociodemographic, Clinical, and Psychological Correlates. Brain Sci. 2024 Jun 3;14(6):573. doi: 10.3390/brainsci14060573. PubMed PMID: 38928572; PubMed Central PMCID: PMC11201712.
AÑO: 2024; IF: 2.7
|